Inaugural Retina Race a great success


Race, at the 12th EURETINA Congress in Milan[/caption]
The Arena Civica, Parco Sempione, was the location for the inaugural Retina Race, which took place during the 12th EURETINA Congress in Milan. The race was held in aid of ORBIS, organised by EURETINA and kindly sponsored by Alcon and Novartis. Approximately 75 runners registered to take part and 56 ran on the day, with ophthalmologists and industry colleagues across all levels from around the world taking part. There were eight categories, split across age and gender, with runners varying in age from 23 to 63 years, so there were plenty of medals to be won. Emilio Fernandez, a Spanish sales executive with Novartis, was the overall winner with a very impressive time of 18 minutes and 33 seconds. Stephane Wolf, global associate brand director, Lucentis at Novartis, praised those who took part in the race and said he hoped the race would continue to grow with more ophthalmologists taking part when it is held in Hamburg, Germany to coincide with the 13th EURETINA Congress. “We are extremely proud so many people turned up today for this charity event. It was a beautiful inaugural race, which will be held every year now and we are sure in 10 years’ time there will be thousands of runners and we are sure people will look back on this day,†said Clemens Jakobi, region Europe franchise head ophthalmics, Novartis.Â
Latest Articles
ESCRS Today 2025: Happy Anniversaries!
ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.
ESCRS Today 2025: A Congress for Everyone
From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.
Beyond the Numbers
Empowering patient participation fosters continuous innovation in cataract surgery.
Thinking Beyond the Surgery Room
Practice management workshop focuses on financial operations and AI business applications.
Aid Cuts Threaten Global Eye Care Progress
USAID closure leads retreat in development assistance.
Supplement: ESCRS Clinical Trends Series: Presbyopia
Debate: FS-LASIK or KLEx for Hyperopia?
FS-LASIK has more of a track record, but KLEx offers advantages.
Four AI Applications Ready for Practice
Commercial offerings may save time, improve practice and research.
Perioperative Medication Regimens for Cataract Surgery
Randomised controlled clinical trial results provide evidence-based guidance.